inMateriis Company Profile

Background

Founded in 2013 by Dr. Inés Jiménez Palomar, inMateriis is a scientific innovation center based in Guadalajara, Jalisco, Mexico. The company is dedicated to democratizing science by developing low-cost, high-impact medical solutions through advanced material technologies and additive manufacturing processes. Their mission encompasses three main objectives:

1. Bringing science closer to the general public.
2. Providing a collaborative laboratory space for young scientists to develop scientific-technological projects.
3. Developing projects that have a social impact by reducing medical device costs and improving quality of life.

inMateriis operates as an open-door scientific laboratory and workspace, serving as a launchpad for technology developed by academia and scientific entrepreneurs. The company specializes in materials science innovations and additive manufacturing, focusing on customized solutions for the healthcare sector.

Key Strategic Focus

inMateriis' strategic focus includes:

Core Objectives: To make scientific innovation accessible to everyone by fostering interdisciplinary collaboration and developing cost-effective medical solutions.

Areas of Specialization: Materials science, additive manufacturing, and biomedical applications.

Key Technologies Utilized: 3D printing technologies, material characterization, and biocompatible materials.

Primary Markets Targeted: Healthcare sector, with a focus on medical devices and implants.

Financials and Funding

Specific details regarding inMateriis' total funds raised and recent funding rounds are not publicly disclosed. The company has received support from government entities such as the National Council of Science and Technology (CONACYT) and the Ministry of Economy in Mexico. This support has been instrumental in advancing their projects, including the development of 3D-printed bone substitutes and other biomedical applications.

Pipeline Development

inMateriis is involved in several key projects:

3D-Printed Bone Substitutes: Development of biocompatible materials for maxillofacial surgeries, aiming to provide personalized, low-cost implants.

Spineo Project: Design and manufacturing of PEEK (Polyetheretherketone) boxes for disc herniation treatments.

BioMai Project: Production of bacterial cellulose from mango waste for biomedical applications, targeting skin lesions in diabetic patients and burn victims.

These projects are in various stages of development, with some undergoing clinical trials and others in the prototyping phase. The company continues to collaborate with academic institutions and research centers to advance these initiatives.

Technological Platform and Innovation

inMateriis distinguishes itself through several technological platforms and innovations:

Proprietary Technologies: Development of biocompatible materials suitable for 3D printing applications in the medical field.

Significant Scientific Methods: Utilization of advanced 3D printing techniques for creating customized medical implants and devices.

AI-Driven Capabilities: While specific AI applications are not detailed, the company's focus on innovative material science suggests potential integration of AI in material characterization and design processes.

Leadership Team

The leadership team at inMateriis includes:

Dr. Inés Jiménez Palomar: Founder and CEO. She holds a Ph.D. in Materials Science from Queen Mary University of London and has been recognized with the 2019 Innovative Entrepreneur Award from AMEXME.

Jorge Pérez Naitoh: Managing and Innovation Director. He holds a degree in Biomedical Engineering and is responsible for overseeing the company's innovation strategies and project development.

Market Insights and Competitor Analysis

The market for 3D-printed medical devices is expanding, driven by the demand for personalized healthcare solutions and cost-effective treatments. Advancements in material science and additive manufacturing technologies are enabling the development of customized implants and prosthetics, presenting significant growth opportunities.

inMateriis operates in a competitive landscape with several key players:

Materialise NV: A global leader in 3D printing software and services, offering solutions for medical device manufacturing.

Stratasys Ltd.: Provides 3D printing solutions for medical applications, including patient-specific surgical planning and implants.

3D Systems Corporation: Offers a range of 3D printing technologies for medical device manufacturing, including biocompatible materials.

These competitors have established a strong presence in the market, offering comprehensive solutions for 3D-printed medical devices.

Strategic Collaborations and Partnerships

inMateriis has formed strategic alliances with various institutions:

University of Guadalajara (UDG): Collaborates on projects, research papers, and joint thesis projects.

CIATEJ (Center for Research and Assistance in Technology and Design of Jalisco): Collaborates on material characterization and testing.

These partnerships enhance inMateriis' research capabilities and facilitate the commercialization of their innovations.

Operational Insights

inMateriis differentiates itself through its focus on low-cost, high-impact medical solutions and its commitment to democratizing science. The company's interdisciplinary approach and open-lab policy foster innovation and collaboration, setting it apart from competitors.

Strategic Opportunities and Future Directions

inMateriis is well-positioned to capitalize on the growing demand for personalized medical devices and the expansion of 3D printing technologies in healthcare. Future opportunities include: